Literature DB >> 10559637

Modulation of cell differentiation in perfusion culture.

W W Minuth1, P Steiner, R Strehl, K Schumacher, U de Vries, S Kloth.   

Abstract

An in vitro model was used to investigate the terminal differentiation mechanisms leading from embryonic to adult renal tissue. For these experiments the capsula fibrosa with adherent embryonic tissue was isolated from neonatal rabbit kidneys. These explants were mounted onto special tissue carriers and cultured in medium containing serum for 24 h. During that time collecting duct (CD) cells grew out and formed a monolayered epithelium covering the whole surface of the explant. The carriers were then transferred to perfusion culture containers to obtain an optimal degree of differentiation. A special type of container allowed us to continuously superfuse the epithelia with individual media on the luminal and basal sides. Using this method it became possible to culture embryonic CD epithelia in a fluid gradient for weeks. The epithelia were superfused with standard Iscove's modified Dulbecco's medium (IMDM) on the basal side, while IMDM containing additional NaCl was used on the luminal side. In controls IMDM was superfused on both the luminal and basal sides. It was found that the degree of differentiation in the CD epithelia is dependent on the influence of fluid gradient exposure. Perfusion culture under isotonic conditions revealed that less than 5% of cells were immunopositive for principal and intercalated cell features, while epithelia cultured in a luminal-basal gradient showed more than 80% positive cells. Immunoreactivity for characteristic markers started to develop after an unexpectedly long latent period of 3-6 days, then increased continuously during the following 5 days and reached a maximum on day 14. After switching back from the gradient to isotonic culture conditions the immunoreactivity for some markers decreased within 5 days, while other characteristic features remained stable. Thus, differentiation was not only under the control of growth factors but was also regulated by the electrolyte environment. Copyright 1999 S. Karger AG,Basel

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10559637     DOI: 10.1159/000020637

Source DB:  PubMed          Journal:  Exp Nephrol        ISSN: 1018-7782


  6 in total

1.  Bridging the gap between traditional cell cultures and bioreactors applied in regenerative medicine: practical experiences with the MINUSHEET perfusion culture system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Cytotechnology       Date:  2015-04-17       Impact factor: 2.058

2.  The influence of culture media on embryonic renal collecting duct cell differentiation.

Authors:  K Schumacher; R Strehl; S Kloth; M Tauc; W W Minuth
Journal:  In Vitro Cell Dev Biol Anim       Date:  1999-09       Impact factor: 2.416

3.  Sphingosine kinase and sphingosine-1-phosphate regulate epithelial cell architecture by the modulation of de novo sphingolipid synthesis.

Authors:  Bruno Jaime Santacreu; Lucila Gisele Pescio; Daniela Judith Romero; Gerardo Raúl Corradi; Norma Sterin-Speziale; Nicolás Octavio Favale
Journal:  PLoS One       Date:  2019-03-21       Impact factor: 3.240

4.  Regulation of constitutive vascular endothelial growth factor secretion in retinal pigment epithelium/choroid organ cultures: p38, nuclear factor κB, and the vascular endothelial growth factor receptor-2/phosphatidylinositol 3 kinase pathway.

Authors:  Alexa Klettner; Daniel Westhues; Jens Lassen; Sofia Bartsch; Johann Roider
Journal:  Mol Vis       Date:  2013-01-03       Impact factor: 2.367

5.  Supportive development of functional tissues for biomedical research using the MINUSHEET® perfusion system.

Authors:  Will W Minuth; Lucia Denk
Journal:  Clin Transl Med       Date:  2012-10-05

6.  Fucoidan reduces secretion and expression of vascular endothelial growth factor in the retinal pigment epithelium and reduces angiogenesis in vitro.

Authors:  Michaela Dithmer; Sabine Fuchs; Yang Shi; Harald Schmidt; Elisabeth Richert; Johann Roider; Alexa Klettner
Journal:  PLoS One       Date:  2014-02-18       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.